Out with the Old, In with CabeNUva: The First and Only Long-Acting Injectable HIV treatment

Rochester, NY US
June 14, 2021

The purpose of this continuing education is to provide more insight on a new FDA-approved HIV-1 therapy. This therapy is considered to be novel, as there are currently no long-acting injectable complete HIV-1 therapies on the market. This learning experience will provide more insight on the epidemiology and pathophysiology of HIV, the current treatments available and specific information pertinent to Cabenuva including, but not limited to, the medication regimen, indication, safety information, and the trials that were completed to assess efficacy and safety of this new regimen.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Summarize the epidemiology and pathophysiology of HIV and the targets of antiretroviral drug therapy on viral replication
  2. Recognize key information regarding Cabenuva, including but not limited to mechanism of action, dosing, administration, safety and tolerability
  3. Evaluate current literature surrounding Cabenuva and analyze how these findings have impacted clinical practice

Pharmacy technician learning objectives

  1. Summarize the epidemiology and pathophysiology of HIV and the targets of antiretroviral drug therapy on viral replication
  2. Recognize key information regarding Cabenuva, including but not limited to mechanism of action, dosing, administration, safety and tolerability
  3. Recognize Cabenuva’s relevant dispensing information
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
06/14/2021
Course expires: 
07/28/2021
Event starts: 
06/14/2021 - 12:00pm
Event ends: 
06/14/2021 - 1:00pm
Cost:
$0.00
University of Rochester Medical Center
601 Elmwood Ave.
Rochester, NY 14642
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose.
 
Planning committee members
 
Erica Dobson, PharmD
Manager of Pharmacy Services at Accountable Health Partners
University of Rochester Medical Center
 
Maila Lowery
Secretary IV
University of Rochester Medical Center
 
Course reviewer
 
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient, Inc.
 
Presenter
 
Paula Yonosko, PharmD
PGY1 Community Pharmacy Resident
University of Rochester Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-21-052-L01-P
Universal Activity Number: JA0006103-9999-21-052-L01-T

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician

Price

Cost:
$0.00
Please login or register to take this course.